Ligand Pharmaceuticals reported $4.35M in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acorda Therapeutics ACOR:US $ -6.2M 1.23M
Agenus AGEN:US $ -43.28M 8.94M
Amgen AMGN:US $ 3004M 337M
Arrowhead Research ARWR:US $ -70306000 114.46M
Baxter International BAX:US $ 787M 124M
Bristol Myers Squibb BMY:US $ 5780M 8M
Clovis Oncology CLVS:US $ -57.48M 9.04M
Eli Lilly And LLY:US $ 1999.4M 1006.2M
Enanta Pharmaceuticals ENTA:US $ -31.82M 1.2M
Gilead Sciences GILD:US $ 2585M 837M
Glaxosmithkline GSK:US $ 2447M 673M
GlaxoSmithKline GSK:LN 2447M 673M
Harsco HSC:US $ 49.67M 1.21M
Insmed INSM:US $ -98081000 92K
Karyopharm Therapeutics KPTI:US $ -42759000 8.35M
Lannett LCI:US $ -12.48M 3.96M
Macrogenics MGNX:US $ -38931000 24.79M
Pacira Pharmaceuticals PCRX:US $ 34.04M 7.72M
Pfizer PFE:US $ 12921M 1739M
Sangamo Biosciences SGMO:US $ -42.85M 0.42M
Spectrum Pharmaceuticals SPPI:US $ -25.32M 11.33M
Teva Pharmaceutical Industries TEVA:US $ 1092M 20M
Veracyte VCYT:US $ -0.94M 7.75M